BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Garza-Campos A, Prieto-Correa JR, Domínguez-Rosales JA, Hernández-Nazará ZH. Implications of receptor for advanced glycation end products for progression from obesity to diabetes and from diabetes to cancer. World J Diabetes 2023; 14(7): 977-994 [PMID: 37547586 DOI: 10.4239/wjd.v14.i7.977]
URL: https://www.wjgnet.com/1948-9358/full/v14/i7/977.htm
Number Citing Articles
1
Ombretta Repetto, Roberto Vettori, Agostino Steffan, Renato Cannizzaro, Valli De Re. Circulating Proteins as Diagnostic Markers in Gastric CancerInternational Journal of Molecular Sciences 2023; 24(23): 16931 doi: 10.3390/ijms242316931
2
Dong Peng, Ying-Chun Xiang, Kai-Lin Tang, Yan-Yu Qiu. Impact of preoperative type 2 diabetes mellitus on the outcomes of patients with gastric cancer following gastrectomy: Analysis of 834 patients using propensity score matchingBiomedical Reports 2023; 19(6) doi: 10.3892/br.2023.1679
3
İrfan KÜÇÜK, Ersin TURAL, Yusuf YAZGAN, Başak ÇAKIR GÜNEY, İdris YILDIRIM, Tuğba AKBAŞ ŞİMŞEK, Musa SALMANOĞLU. Serum-soluble receptor for advanced glycation end-products values might have diagnostic and prognostic significances in ulcerative colitisJournal of Health Sciences and Medicine 2023; 6(6): 1398 doi: 10.32322/jhsm.1343016
4
Tamara S. Vatseba, Liubov K. Sokolova, Vasyl Ye. Neyko, Valentyna V. Dzvonkovska, Oksana V. Muravlova, Volodymyr V. Derpak. THE INFLUENCE OF DIABETES-ASSOCIATED FACTORS OF ONCOGENESIS ON THE RISK OF BREAST AND ENDOMETRIAL CANCER AND ON THE SURVIVAL OF WOMEN WITH THIS CANCERClinical and Preventive Medicine 2024; (2): 99 doi: 10.31612/2616-4868.2.2024.13
5
Gowri Palanissami, Solomon F.D. Paul. AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancersExploration of Targeted Anti-tumor Therapy 2023; : 812 doi: 10.37349/etat.2023.00170